Zoledronic Acid in the Management of Patients With Asymptomatic/Early Stage Multiple Myeloma

NCT00216151 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Study terminated due to low patient enrollment.

Conditions

Multiple Myeloma

Interventions

DRUG: Zoledronic Acid

Sponsor

Hoosier Cancer Research Network

Collaborators

[object Object]
[object Object]